Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) FCF Margin (2016 - 2025)

BioCorRx (BICX) has disclosed FCF Margin for 15 consecutive years, with 225.5% as the latest value for Q4 2025.

  • Quarterly FCF Margin changed N/A to 225.5% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 173.55% through Dec 2025, up 1412853.0% year-over-year, with the annual reading at 288.28% for FY2025, 1401379.0% up from the prior year.
  • FCF Margin hit 225.5% in Q4 2025 for BioCorRx, down from 99.88% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 70.97% in Q2 2025 to a low of 9383.09% in Q1 2024.
  • Historically, FCF Margin has averaged 3395.86% across 5 years, with a median of 2864.85% in 2023.
  • Biggest five-year swings in FCF Margin: tumbled -840056bps in 2024 and later soared 887188bps in 2025.
  • Year by year, FCF Margin stood at 4757.39% in 2021, then surged by 89bps to 542.44% in 2022, then tumbled by -420bps to 2818.86% in 2023, then crashed by -33bps to 3754.59% in 2024, then soared by 94bps to 225.5% in 2025.
  • Business Quant data shows FCF Margin for BICX at 225.5% in Q4 2025, 99.88% in Q3 2025, and 70.97% in Q2 2025.